Antifibrotic Effects of a Recombinant Adeno-Associated Virus Carrying Small Interfering RNA Targeting TIMP-1 in Rat Liver Fibrosis

被引:36
作者
Cong, Min [1 ]
Liu, Tianhui [1 ]
Wang, Ping [1 ]
Fan, Xu [1 ]
Yang, Aiting [1 ]
Bai, Yanfeng [1 ]
Peng, Zhen [1 ]
Wu, Peng [1 ]
Tong, Xiaofei [1 ]
Chen, Jing [1 ]
Li, Hai [1 ]
Cong, Rui [1 ]
Tang, Shuzhen [1 ]
Wang, Baoen [1 ]
Jia, Jidong [1 ]
You, Hong [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing 100050, Peoples R China
基金
中国国家自然科学基金;
关键词
HEPATIC STELLATE CELLS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; EXPRESSION; MECHANISMS; APOPTOSIS; REVERSIBILITY; TGF-BETA-1; FIBROGENESIS; DEGRADATION;
D O I
10.1016/j.ajpath.2013.01.036
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
Elevated tissue inhibitor of metalloproteinase 1 (TIMP-1) expression contributes to excess production of extracellular matrix in liver fibrosis. Herein, we constructed a recombinant adeno-associated virus (rAAV) carrying siRNA of the TIMP-1 gene (rAAV/siRNA-TIMP-1) and investigated its effects on Liver fibrosis in rats. Two models of rat liver fibrosis, the carbon tetrachloride and bile duct ligation models, were treated with rAAV/siRNA-TIMP-1. In the carbon tetrachloride model, rAAV/siRNA-TIMP-1 administration attenuated fibrosis severity, as determined by histologic analysis of hepatic collagen accumulation, hydroxyproline content, and concentrations of types I and III collagen in Livers and sera. Levels of mRNA and active matrix metalloproteinase (MMP) 13 were elevated, whereas levels of mRNA and active MMP-2 were decreased. Moreover, a marked decrease was noted in the expression of alpha-smooth muscle actin, a biomarker of activated hepatic stellate cells (HSCs), and transforming growth factor-beta 1, critical for the development of Liver fibrosis. Similarly, rAAV/siRNA-TIMP-1 treatment significantly alleviated bile duct Ligation-induced liver fibrosis. Furthermore, this treatment dramatically suppressed TIMP-1 expression in HSCs from both model rats. These data indicate that the administration of rAAV/siRNA-TIMP-1 attenuated liver fibrosis by directly elevating the function of MMP-13 and diminishing activated HSCs. It also resulted in indirect decreased expression of type I collagen, MMP-2, and transforming growth factor-beta 1. In conclusion, rAAV/siRNA-TIMP-1 may be an effective antifibrotic gene therapy agent.
引用
收藏
页码:1607 / 1616
页数:10
相关论文
共 41 条
[1]
CX3CL1-CX3CR1 Interaction Prevents Carbon Tetrachloride-Induced Liver Inflammation and Fibrosis in Mice [J].
Aoyama, Tomonori ;
Inokuchi, Sayaka ;
Brenner, David A. ;
Seki, Ekihiro .
HEPATOLOGY, 2010, 52 (04) :1390-1400
[2]
Enhanced matrix degradation after withdrawal of TGF-β1 triggers hepatocytes from apoptosis to proliferation and regeneration [J].
Arendt, E ;
Ueberham, U ;
Bittner, R ;
Gebhardt, R ;
Ueberham, E .
CELL PROLIFERATION, 2005, 38 (05) :287-299
[3]
Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[4]
TGFβ1 in liver fibrosis:: time to change paradigms? [J].
Bauer, M ;
Schuppan, D .
FEBS LETTERS, 2001, 502 (1-2) :1-3
[5]
Extracellular matrix degradation and the role of hepatic stellate cells [J].
Benyon, RC ;
Arthur, MJP .
SEMINARS IN LIVER DISEASE, 2001, 21 (03) :373-384
[6]
TGF-β1 Gene Silencing for Treating Liver Fibrosis [J].
Cheng, Kun ;
Yang, Ningning ;
Mahato, Ram I. .
MOLECULAR PHARMACEUTICS, 2009, 6 (03) :772-779
[7]
Suppression of tissue inhibitor of metalloproteinase-1 by recombinant adeno-associated viruses carrying siRNAs in hepatic stellate cells [J].
Cong, Min ;
Liu, Tianhui ;
Wang, Ping ;
Xu, Yong ;
Tang, Shuzhen ;
Wang, Baoen ;
Jia, Jidong ;
Liu, Yong ;
Hermonat, Paul L. ;
You, Hong .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (05) :685-692
[8]
Doh KO, 2008, KOREAN J PHYSIOL PHA, V12, P1, DOI 10.4196/kjpp.2008.12.1.1
[9]
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis [J].
Elsharkawy, AM ;
Oakley, F ;
Mann, DA .
APOPTOSIS, 2005, 10 (05) :927-939
[10]
Fan X, 2013, CELL BIOL INT, DOI [10.1002/cbin.10035, DOI 10.1002/THIN.10035]